Mohamed Gijon

发表

Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses

C. Melief, C. Melief, P. Symonds, 2020, Journal for immunotherapy of cancer.

PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy

P. Symonds, R. Metheringham, S. Paston, 2022, Journal for ImmunoTherapy of Cancer.

T cell repertoire to citrullinated self-peptides in healthy humans is not confined to the HLA-DR SE alleles; Targeting of citrullinated self-peptides presented by HLA-DP4 for tumour therapy

P. Symonds, R. Metheringham, W. Xue, 2019, Oncoimmunology.

The Clinical and Prognostic Significance of Protein Arginine Deiminases 2 and 4 in Colorectal Cancer

M. Toss, R. Metheringham, S. Paston, 2021, Pathobiology.

Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial

R. Plummer, H. Pandha, P. Lorigan, 2018, Oncoimmunology.

Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-Cell-Mediated Antitumor Immunity.

P. Symonds, R. Metheringham, W. Xue, 2016, Cancer research.

Citrullinated α-enolase is an effective target for anti-cancer immunity

P. Symonds, R. Metheringham, W. Xue, 2017, Oncoimmunology.

Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy

P. Symonds, R. Metheringham, A. Miles, 2021, Journal for ImmunoTherapy of Cancer.

The clinical and prognostic significance of Protein Arginine Deiminase 2 and 4 (PADI2 & PADI4) in colorectal cancer

M. Toss, R. Metheringham, S. Paston, 2020 .

Protein Arginine Deiminase 2 and 4 (PAD2 & PAD4) are independent predictors of good prognosis in colorectal cancer

R. Metheringham, S. Paston, L. Durrant, 2020, medRxiv.